Dec 30, 2025 • Stock Traders Daily
SOMEWHAT-BEARISH
Price-Driven Insight from (CC) for Rule-Based Strategy
This article provides a price-driven analysis for The Chemours Company (NYSE: CC), highlighting a near-term neutral sentiment amidst mid and long-term weakness. It details an exceptional risk-reward short setup, along with various AI-generated trading strategies tailored for different risk profiles and holding periods, such as position trading, momentum breakout, and risk hedging. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
Dec 29, 2025 • openPR.com
BULLISH
Titanium(IV) Chloride Market Growth Analysis Indicates US$ 12.35 Billion Opportunity by 2031 | Chemours, Tronox, Venator, INEOS
The global Titanium(IV) Chloride market, valued at US$9.93 billion in 2024, is projected to reach US$12.35 billion by 2031 with a CAGR of 3.2% between 2025 and 2031, according to a report by QY Research. This growth is driven by its critical role in producing titanium metal and titanium dioxide. Key industry players include Chemours, Tronox, Venator, and INEOS, with the market segmented by type (High Titanium Slag, Rutile) and application (Titanium Dioxides Manufacturing, Precursor of Titanium Metals and Powders, Catalysts).
Dec 25, 2025 • Simply Wall Street
SOMEWHAT-BULLISH
Is Chemours A Bargain After PFAS Headwinds And A 55% Three Year Share Price Slide?
Despite a significant three-year share price slide, Chemours (NYSE: CC) appears undervalued based on two key metrics: Discounted Cash Flow (DCF) analysis and Price to Sales (PS) ratio. The DCF model suggests the stock is 71.0% undervalued, projecting a substantial recovery in free cash flow, while its PS ratio of 0.31x is well below industry averages and its own Fair Ratio of 0.80x. The company's valuation is influenced by ongoing environmental liabilities related to PFAS chemicals and efforts to streamline its product portfolio.
Dec 22, 2025 • openPR.com
BULLISH
Fluorochemicals Market Is Going to Boom | Major Giants Chemours, Daikin, Arkema, Solvay, 3M, Honeywell
The global Fluorochemicals Market is projected to grow at a CAGR of 7.4% from 2024 to 2033, reaching $58.4 billion by 2033, up from $32.9 billion in 2024. Key market drivers include demand for HVAC, electric vehicles, pharmaceuticals, and chemical resistance, facing challenges from environmental regulations and PFAS concerns. Asia-Pacific is identified as both the dominating and fastest-growing region.
Dec 22, 2025 • FinancialContent
BULLISH
The Billion-Dollar Gamble: Why Alta Fundamental Advisers is Doubling Down on a Battered Chemours
Alta Fundamental Advisers has made a significant contrarian investment in The Chemours Company (NYSE: CC), acquiring 800,000 shares and 200,000 call options despite the stock's recent 32% decline. This move signals a belief that the market has mispriced Chemours following accounting scandals, dividend cuts, and environmental litigation, particularly after a landmark PFAS settlement provided a clearer financial outlook for the company. The investment by Alta suggests a potential turning point for Chemours and could serve as a bellwether for how the financial markets price the risks associated with "forever chemical" litigation.
Dec 19, 2025 • Plasteurope.com
NEUTRAL
CHEMOURS: President of titanium dioxide unit departs / Successor to take over in early 2026
Damián Gumpel, head of Chemours' titanium dioxide business, is leaving the company after only starting at the beginning of the year. Michael Foley is slated to take over the role in February 2026, with CEO Denise Dignam heading the division in the interim. This departure follows a difficult year for Chemours, marked by underperforming titanium dioxide business and significant PFAS-related compensation payments.